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Ferroportin (FPN1) is the only iron exporter so far identified in mammals, encoded by
the SLC40A1 gene (2q32.2). The main function of FPN1 is to transfer dietary iron from
the enterocytes of the duodenum and from cells of iron storage, known as
macrophages, into the bloodstream. FPN1 function is negatively regulated by the
hormone hepcidin. Hepcidin binds to FPN1 and triggers its internalization and
degradation, limiting iron export (Fig. 1).
A) B)
Mutations in SLC40A1 gene may affect differently the FPN1 structure and function,
originating two phenotypically distinct rare hereditary autosomal dominant diseases
of iron overload [1,2].
Fig. 1: Effect of hepcidin on iron transport in the 
duodenum and in macrophages
A) After dietary iron is taken up by duodenal enterocytes, 
ferroportin mediates iron export across the basolateral 
membrane into the plasma.
B) After red blood cells are phagocytosed by macrophages, 
hemoglobin-derived iron is exported by ferroportin into 
the plasma. 
In both of these cell types, hepcidin limits iron export by 
triggering the internalization and degradation of 
ferroportin in lysosomes. Adapted from [1].
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Hereditary Hemochromatosis type IV Ferroportin Disease 
 Although these three SLC40A1 genetic variants are already reported in public databases (Ensembl, ClinVar), they were not known to be present in the Portuguese population.
 Detailed clinical evaluation of patients in addition to in silico analyses and in vitro functional studies are useful to reveal the pathogenic effect of mutations in FPN1 function, 
expression and mechanism of regulation by hepcidin.
 As these diseases have an autosomal-dominant inheritance with incomplete penetrance, family screening is mandatory since siblings and offspring have a 50% chance of 
carrying the pathogenic mutation. 
1.To search for mutations in six iron metabolism related genes in patients suspected
to have Non-classic Hereditary Hemochromatosis. 
2.To identify which cases are associated with SLC40A1 pathogenic mutations and to 
investigate by in silico analyses the underlying pathophysiologic mechanisms.  
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Subjects analyzed: 335 individuals suspected of having Non-Classical Hereditary
Hemochromatosis (HH).
Six genes related with iron metabolism (HFE, HAMP, HJV, TFR2, SLC40A1 and FTL)
were analysed by SSCP, dHPLC or NGS.
NGS used TruSeq or Nextera XT libraries and a MiSeq platform (Illumina)
Validation of genetic variants found was performed by Sanger sequencing.
Predictive consequences of variants at protein level were evaluated using
PolyPhen-2 and SIFT softwares.
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• Reported functional studies indicate 
that this mutation does not affect the 
presence of the protein on the cell 
surface but causes a gain of FPN1 
function and hepcidin resistance [3].
Three SLC40A1 rare pathogenic variants were detected in three different patients,
presenting two distinct phenotypes:
1. Ferroportin Disease (FD)
One missense mutation, c.238G>A, located in exon 3 and one deletion
c.485_487delTTG in exon 5, were found in heterozygosity in two women presenting
with hyperferritinemia and low transferrin saturation.
2. Hereditary Hemochromatosis type IV
The other missense mutation, c.610G>A, was also found in heterozygosity in a woman
presenting hyperferritinemia high transferrin saturation and liver iron overload.
p.Gly80Ser
• PolyPhen-2 software predicts p.Gly80Ser 
is probably a damaging mutation (score = 
1.000; Fig. 2);
• It is located at the cytosolic bottom of
the second intermembrane segment of
FPN1 [3];
• Reported in vitro studies have shown a
reduced iron export capacity and less
presence at cell surface [3,4,5].
p.Val162del
• SIFT Indel software predicts p.Val162del
is damaging for the structure and
function of FPN1 (score = 0.858);
• It is located in a cytosolic loop of FNP1
between transmembrane domains 4 and
5 [3];
• Reported in vitro studies have shown the
deletion impairs the correct folding of
the protein and reduces its iron export
function [3,4,5].
• p.Val162del has been described in
several families of different ethnic origin
suggesting it is the most common
mutation of FNP1 [6,7].
FPN1 Loss-of-function → Ferroportin disease
p.Gly204Ser
• Affects an extracellular segment between transmembrane domains 5 and 6 [3];
• PolyPhen-2 classifies this mutation as probably damaging to protein structure and
function (score = 1.000; Fig. 3);
Fig. 3: Prediction of the pathogenic effect of
p.Gly204Ser alteration on FPN1 protein by
PolyPhen-2 software.
FPN1 Gain-of-function → Hereditary Hemochromatosis type IV
Fig. 2: Prediction of the pathogenic effect of p.Gly80Ser
alteration on FPN1 protein by PolyPhen-2 software.
Fig. 4: Schematic representattion of
mutations on FPN protein (model of Liu
et al, 2005 [8]). The three mutations
reported in this study are underlined.
• p.Gly204Ser does not appear to cause FD. 
Repor ed func ional studies indicate that
this mutation do s n affect the
presenc of he protein on the cell surface
but causes hepcidin resistance [7].
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